Junipers of Various Origins as Potential Sources of the Anticancer Drug Precursor Podophyllotoxin

• Main Authors: Diana I. Ivanova, Paraskev T. Nedialkov, Alexander N. Tashev, Marta Olech, Renata Nowak, Yana E. Ilieva, Zlatina K. Kokanova-Nedialkova, Teodora N. Atanasova, George Angelov, Hristo M. Najdenski
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Molecules
• Subjects: cytotoxic agents; <i>Juniperus</i> L.; podophyllotoxin; LC-MS; HRMS
• Online Access: https://www.mdpi.com/1420-3049/26/17/5179

Juniper representatives are natural sources of plenty of bioactive metabolites and have been used since ancient times as folk remedies against tapeworms, warts, cancer, etc. The antiproliferative activities of junipers are attributed to podophyllotoxin (PPT), which is a precursor for the synthesis of efficient anticancer drugs. However, the natural sources of PPT, <i>Sinopodophyllum hexandrum</i> (Royle) T. S. Ying and <i>Podophyllum peltatum</i> L., are already endangered species because of their intensive industrial exploitation. Therefore, identification of other sources of PPT is necessary. This study is a broad comparative investigation of junipers, for which original sources have been accessed from different continents of the world. The present research is aimed at the identification of species, producing PPT and other lignans at concentrations that are sufficient for the high antiproliferative activity of the corresponding extracts. Cytotoxic juniper leaf extracts demonstrated a broad spectrum of activity on a panel of cancer cell lines. The antiproliferative properties of junipers were attributed to the combined activity of great diversity of lignans (podophyllotoxin, deoxypodophyllotoxin, β-peltatin, yatein, matairesinol, anhydropodorhizol, etc.), detected by UHPLC-HRMS and LC-ESI-MS/MS in the corresponding extracts. Several species of the genus <i>Juniperus</i> L. were outlined as perspective sources of drug precursors with potential pharmaceutical applications.